These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


306 related items for PubMed ID: 50328

  • 21. Recombinant fibrinogen studies reveal that thrombin specificity dictates order of fibrinopeptide release.
    Mullin JL, Gorkun OV, Binnie CG, Lord ST.
    J Biol Chem; 2000 Aug 18; 275(33):25239-46. PubMed ID: 10837485
    [Abstract] [Full Text] [Related]

  • 22. Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen.
    Rooney MM, Mullin JL, Lord ST.
    Biochemistry; 1998 Sep 29; 37(39):13704-9. PubMed ID: 9753458
    [Abstract] [Full Text] [Related]

  • 23. Determination of human fibrinopeptide A by radioimmunoassay in purified systems and in the blood.
    Budzynski AZ, Marder VJ.
    Thromb Diath Haemorrh; 1975 Dec 15; 34(3):709-17. PubMed ID: 1209541
    [Abstract] [Full Text] [Related]

  • 24. A synthetic analog of fibrinogen alpha 27-50 is an inhibitor of thrombin.
    Binnie CG, Lord ST.
    Thromb Haemost; 1991 Feb 12; 65(2):165-8. PubMed ID: 2053103
    [Abstract] [Full Text] [Related]

  • 25. Immunochemical studies of antisera to human fibrinopeptide-B.
    Butler VP, Weber DA, Nossel HL, Tse-Eng D, LaGamma KS, Canfield RE.
    Blood; 1982 May 12; 59(5):1006-12. PubMed ID: 6176283
    [Abstract] [Full Text] [Related]

  • 26. Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization.
    Ruf W, Bender A, Lane DA, Preissner KT, Selmayr E, Müller-Berghaus G.
    Biochim Biophys Acta; 1988 May 12; 965(2-3):169-75. PubMed ID: 3365451
    [Abstract] [Full Text] [Related]

  • 27. Mediation of fibrin-induced release of von Willebrand factor from cultured endothelial cells by the fibrin beta chain.
    Ribes JA, Ni F, Wagner DD, Francis CW.
    J Clin Invest; 1989 Aug 12; 84(2):435-42. PubMed ID: 2788172
    [Abstract] [Full Text] [Related]

  • 28. Surface-dependent fibrinopeptide A accessibility to thrombin.
    Geer CB, Rus IA, Lord ST, Schoenfisch MH.
    Acta Biomater; 2007 Sep 12; 3(5):663-8. PubMed ID: 17540627
    [Abstract] [Full Text] [Related]

  • 29. Analysis of A alpha 251 fibrinogen: the alpha C domain has a role in polymerization, albeit more subtle than anticipated from the analogous proteolytic fragment X.
    Gorkun OV, Henschen-Edman AH, Ping LF, Lord ST.
    Biochemistry; 1998 Nov 03; 37(44):15434-41. PubMed ID: 9799505
    [Abstract] [Full Text] [Related]

  • 30. Fibrinogen Aarhus--a new case of dysfibrinogenemia.
    Hessel B, Stenbjerg S, Dyr J, Kudryk B, Therkildsen L, Blombäck B.
    Thromb Res; 1986 Apr 01; 42(1):21-37. PubMed ID: 2939591
    [Abstract] [Full Text] [Related]

  • 31. Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin.
    Goodwin CA, Kakkar VV, Scully MF.
    Biochem J; 1992 Feb 01; 281 ( Pt 3)(Pt 3):613-8. PubMed ID: 1531588
    [Abstract] [Full Text] [Related]

  • 32. Thrombin-bound structures of designed analogs of human fibrinopeptide A determined by quantitative transferred NOE spectroscopy: a new structural basis for thrombin specificity.
    Ni F, Zhu Y, Scheraga HA.
    J Mol Biol; 1995 Oct 06; 252(5):656-71. PubMed ID: 7563081
    [Abstract] [Full Text] [Related]

  • 33. Thrombin-induced fibrinopeptide release from a fibrinogen variant (fibrinogen Sydney I) with an Aalpha Arg-16----His substitution.
    Southan C, Lane DA, Bode W, Henschen A.
    Eur J Biochem; 1985 Mar 15; 147(3):593-600. PubMed ID: 3979390
    [Abstract] [Full Text] [Related]

  • 34. [Fibrinogen Zürich I: defective fibrinopeptide-A release].
    Hofmann V, Gati WP, Straub PW.
    Schweiz Med Wochenschr; 1977 Oct 15; 107(41):1468. PubMed ID: 918602
    [Abstract] [Full Text] [Related]

  • 35. [Relation between blood coagulability and prognosis in patients with ovarian cancer].
    Sawaguchi K, Narumiya H, Yabushita H, Noguchi M, Nakanishi M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Apr 15; 42(4):313-9. PubMed ID: 2358716
    [Abstract] [Full Text] [Related]

  • 36. Specificity of antisera to human fibrinopeptide A used in clinical fibrinopeptide A assays.
    Nossel HL, Butler VP, Wilner GD, Canfield RE, Harfenist EJ.
    Thromb Haemost; 1976 Feb 29; 35(1):101-9. PubMed ID: 60791
    [Abstract] [Full Text] [Related]

  • 37. Structural basis for sequential cleavage of fibrinopeptides upon fibrin assembly.
    Pechik I, Yakovlev S, Mosesson MW, Gilliland GL, Medved L.
    Biochemistry; 2006 Mar 21; 45(11):3588-97. PubMed ID: 16533041
    [Abstract] [Full Text] [Related]

  • 38. Fibrinopeptides A and B release in the process of surface fibrin formation.
    Riedel T, Suttnar J, Brynda E, Houska M, Medved L, Dyr JE.
    Blood; 2011 Feb 03; 117(5):1700-6. PubMed ID: 21106983
    [Abstract] [Full Text] [Related]

  • 39. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
    Schwartz LB, Bradford TR, Littman BH, Wintroub BU.
    J Immunol; 1985 Oct 03; 135(4):2762-7. PubMed ID: 3161948
    [Abstract] [Full Text] [Related]

  • 40. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF, Pandi L.
    Biochemistry; 2006 Feb 28; 45(8):2657-67. PubMed ID: 16489759
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.